Our results indicated that breast cancer patients with bone metastasis exhibited significantly increased serum BST2 as compared to breast cancer patients without bone metastasis as well as normal healthy individuals (p < .001) (Table 1). This evidence concerns the gene BST2 and bone metastasis.